Mahjoob, Maryam
Cardy, Robyn
Penner, Melanie
Anagnostou, Evdokia
Andrade, Brendan F.
Crosbie, Jennifer
Kelley, Elizabeth
Ayub, Muhammad
Ayub, Muhammad
Brian, Jessica
Iaboni, Alana
Schachar, Russell
Georgiades, Stelios
Nicolson, Rob
Jones, Jessica
Kushki, Azadeh
Funding for this research was provided by:
Canadian Institutes of Health Research
Article History
Received: 15 February 2023
Accepted: 11 March 2024
First Online: 16 March 2024
Competing interests
: This work was supported by research funds from Samsung Canada, Autism Speaks Canada, and Mitacs. All co-authors meet the requirements for authorship and have reviewed and approved this manuscript. Dr Kushki is the inventor of a software called the "Anxiety Meter". She is involved in commercialising the Anxiety Meter (patents US 9,844,332 B2 and US 16/276,208 (pending)) and will financially benefit from its sales. Dr Kushki served on the board of advisors for Shaftesbury, a media company developing virtual reality products for autistic children, from February 2020 to February 2021, and was compensated financially for this role. Dr Kushki has received donations of hardware for her research program from Samsung Canada. Dr Anagnostou reports grants from Roche, grants from Anavex, personal fees from Roche, personal fees from Quadrant, personal fees from Impel, personal fees from Ono, personal fees from Wiley, book royalties from Springer, book royalties from APPI, and non-financial support from AMO Pharma outside the submitted work. In addition, Dr Anagnostou holds a patent on the software called the "Anxiety Meter"; the Anxiety Meter is being commercialised and she will financially benefit from its sales. The other authors report no potential conflicts of interest.